NuShores Biosciences receives $2.8 million contract for intelligent manufacturing automation of bone regeneration technology

NuShores Biosciences, a spin-off company of the University of Arkansas at Little Rock, has received a three-year, $2.8 million contract from the Medical Technology Enterprise Consortium, a biomedical technology consortium associated with the U.S. Army Medical Research and Development Command. The contract will enable NuShores to develop intelligent automated production of its NuCress™ bone void filler scaffold products using its factory-in-a-box concept. Key collaborators on the project include UA Little Rock and MiQ Partners of Cincinnati.

Hydrogel Offers Double Punch Against Orthopedic Bone Infections

Surgery prompted by automobile accidents, combat wounds, cancer treatment and other conditions can lead to bone infections that are difficult to treat and can delay healing until they are resolved. Now, researchers have a developed a double-duty hydrogel that both…